Seaport loads $225M for Karuna vets' voyage to milestones

Seaport Loads $225M For Karuna Vets' Voyage To Milestones

1 week from now

Oct 21, 2024  · Seaport loads up $225M series B to continue Karuna veterans' voyage to clinical milestones. After launching on its maiden voyage in April, Seaport Therapeutics and its crew …

fiercebiotech.com

Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...

1 week from now

BOSTON, October 21, 2024 – Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a …

seaporttx.com

Seaport Loads Up $225M Series B To Continue Karuna Veterans' …

1 week from now

Oct 21, 2024  · Seaport loads up $225M series B to continue Karuna veterans' voyage to clinical milestones jwaldron Mon, 10/21/2024 - 04:43. ... Seaport loads up $225M series B to continue …

biotechjobs.io

Seaport, Six Months Out Of Stealth, Comes Back For $225M Raise

1 week from now

Oct 21, 2024  · Seaport Therapeutics, just six months after emerging from stealth with $100 million, is back with twice that value in additional funding to support its neuropsychiatric …

biospace.com

Seaport Loads Up $225M Series B To Continue Karuna Veterans' …

1 week from now

After launching on its maiden voyage in April, Seaport Therapeutics and its crew of Karuna veterans have loaded up with $225 million in series B fu...

biotech-now.co.uk

Seaport Eyes Platform, Pipeline Growth With $225M Series B

1 week from now

Oct 21, 2024  · Seaport has closed on an oversubscribed $225 million Series B financing, with the proceeds set to be used toward enhancing the platform, and advancing through clinical …

genengnews.com

Former Karuna Crew Quickly Assembles $225M For Next Neuro Bet …

1 week from now

Oct 21, 2024  · Former Karuna crew quickly assembles $225M for next neuro bet at Seaport. Seaport Therapeutics CEO Daphne Zohar at the Endpoints 11 gala (Michael Last …

endpts.com

Brain Drug Developer Seaport Raises Another $225M

1 week from now

Oct 21, 2024  · A young biotechnology company developing drugs for the brain has raised another $225 million from a syndicate of well-known healthcare investors.. Launched in April, Seaport …

biopharmadive.com

Seaport Raises $225M For Brain Drug Development

1 week from now

Seaport Therapeutics, a burgeoning biotechnology company focused on brain-related drug development, has recently secured an additional $225 million from a group of prominent …

patsnap.com

Seaport Eyes Platform, Pipeline Growth With $225M Series B

1 week from now

Oct 21, 2024  · Daphne Zohar, founder and CEO of Seaport Therapeutics Seaport Therapeutics said today it has closed on an oversubscribed $225 million Series B financing, with the …

diwou.com

Matthew Tong On LinkedIn: Seaport Loads Up $225M Series B To …

1 week from now

Seaport Therapeutics, led by the same pioneers who built Karuna Therapeutics, has just secured $225M in #SeriesB funding to advance its pipeline of neuropsychiatric treatments. This …

linkedin.com

David Claveau On LinkedIn: Seaport Loads Up $225M Series B To …

1 week from now

Karuna's veterans, now with Seaport Therapeutics, ... Seaport loads up $225M series B to continue Karuna veterans' voyage to clinical milestones ...

linkedin.com

Mark Benmoise On LinkedIn: Seaport Loads Up $225M Series B To …

1 week from now

Seaport Therapeutics’ recent $225M Series B funding is a powerful signal of the growing focus on neuropsychiatric drug development. With seasoned leaders from…

linkedin.com

Trusted Insight | | Read Investment News | Trusted Insight Platform

1 week from now

Oct 4, 2024  · Seaport Loads $225M For Karuna Vets' Voyage To Milestones October 21, 2024 fiercebiotech.com. LPNEWS The House Fund Scours Uc Berkeley For The Next Perplexity, …

thetrustedinsight.com

Karuna's Captains Set Sail In New Neuropsychiatric Biotech

1 week from now

Apr 9, 2024  · Seaport’s leadership has been buoyed by the fate of Karuna, which was acquired by BMS for $14 billion in December so the Big Pharma could get its hands on what looks set to …

fiercebiotech.com

Seaport Emerges After $100m Raise With Ex-Karuna Team At Helm

1 week from now

Apr 9, 2024  · Seaport is developing oral neuropsychiatric drugs that bypass first-pass metabolism. Robert Barrie April 9, 2024. Bristol-Myers Squibb acquired Karuna for $14bn in late 2023. …

pharmaceutical-technology.com

PureTech Launches Seaport, Hoping To Create Karuna 2.0

1 week from now

Apr 9, 2024  · That deal with Bristol Myers has already generated around $1.1 billion in gross proceeds for PureTech, which initially put in less than $19 million to get Karuna off the ground, …

biopharmadive.com